Found: 11
Select item for more details and to access through your institution.
miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2015, v. 123, n. 2, p. 205, doi. 10.1007/s11060-015-1784-3
- By:
- Publication type:
- Article
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies.
- Published in:
- Journal of Neuro-Oncology, 2013, v. 113, n. 1, p. 1, doi. 10.1007/s11060-013-1084-8
- By:
- Publication type:
- Article
CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 1, p. 37, doi. 10.1007/s11060-012-0948-7
- By:
- Publication type:
- Article
Analysis of extracellular RNA in cerebrospinal fluid.
- Published in:
- Journal of Extracellular Vesicles, 2017, v. 6, n. 1, p. N.PAG, doi. 10.1080/20013078.2017.1317577
- By:
- Publication type:
- Article
A Pilot Proof-Of-Principle Analysis Demonstrating Dielectrophoresis (DEP) as a Glioblastoma Biomarker Platform.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46311-8
- By:
- Publication type:
- Article
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0078115
- By:
- Publication type:
- Article
Differential Expression of miR-145 in Children with Kawasaki Disease.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058159
- By:
- Publication type:
- Article
RDNA-01. microRNA DEGRADATION MEDIATED GENETIC HETEROGENEITY AS A NOVEL MECHANISM FOR TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi221, doi. 10.1093/neuonc/noy148.917
- By:
- Publication type:
- Article
INNV-19. PLASMA EXTRACELLULAR VESICLE GLIAL FIBRILLARY ACIDIC PROTEIN AND TAU AS BIOMARKERS FOR BRAIN CANCER.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi142, doi. 10.1093/neuonc/noy148.592
- By:
- Publication type:
- Article
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 11, p. 1494, doi. 10.1093/neuonc/nox085
- By:
- Publication type:
- Article
Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF).
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0149866
- By:
- Publication type:
- Article